FibroGenesis Identifies Mechanism Responsible for Blocking COV... - 02 July 2020 07:35

HOUSTON, July 2, 2020 /PRNewswire-AsiaNet/ -- -- Regenerative Medicine Company Advances Development of Fibroblast-Based Product as an "Off the Shelf" Cell-Treatment for Coronavirus Acute Respiratory Distress Syndrome (ARDS) FibroGenesis announced today identification of molecular mechan...

  Almost Half of Children Are Not Always Using Soap When Washing... - 01 July 2020 09:01

LONDON, July 1, 2020 /PRNewswire-AsiaNet/ -- Leading hygiene experts are stressing the importance of effective hand hygiene measures and education in schools as children begin returning to educational settings following the COVID-19 pandemic. The calls follow a new global survey conducte...

  Carmine Therapeutics and Takeda Collaborate to Discover and De... - 01 July 2020 09:00

CAMBRIDGE, Mass., July 1, 2020 /PRNewswire-AsiaNet/-- Takeda has also led Carmine's convertible note seed+ funding round by extending a $5M convertible loan to Carmine Carmine Therapeutics announced today that it has signed a research collaboration agreement with Takeda Pharmaceutical Company L...

  Thrombosis Research Institute (TRI) Announce ETHIC Trial to Ev... - 30 June 2020 16:00

LONDON, June 30, 2020 /PRNewswire-AsiaNet/-- Clinical trial will recruit approximately 1400 patients in 10 countries starting in July Participants will be randomised to receive the low molecular weight Heparin enoxaparin or current standard of care for up to 3 weeks from the time of diagn...

  MedAlliance Gains CE Mark Approval for Coronary SELUTION SLR™ ... - 30 June 2020 11:00

NYON, Switzerland, June 30, 2020 /PRNewswire-AsiaNet/ -- MedAlliance has announced the award of its second CE Mark: SELUTION SLR™ 014 PTCA, a novel Sirolimus Drug Eluting Balloon (DEB), for the treatment of coronary arterial disease. This includes indications for both de-novo lesions as well as in-stent...

  Neuro-Sys SAS Launches Innovative In Vivo Services in CNS/PNS ... - 30 June 2020 10:00

GARDANNE, France, June 30, 2020 /PRNewswire-AsiaNet/ -- - French/American Contract Services Organisation boosts its offer to CNS/PNS drug development companies Today Neuro-Sys, pharmacological Contract Research Services company specialising in the R&D and in vitro testing of molecules used to treat ...

  RevImmune Announces Phase II Trial of the T-Cell Growth Factor... - 29 June 2020 23:00

BETHESDA, Maryland, June 29, 2020 /PRNewswire-AsiaNet/ -- - Under Way in Europe Since May, In Preparation in the U.S. - Designated As An Urgent Public Health National Priority In U.K. RevImmune, a privately held biotechnology company developing CYT107 immune therapy for infectious diseases and c...

  COVID-19 Pandemic Brought Under Control in China with Favipira... - 28 June 2020 19:00

BEIJING, China, June 27, 2020, Antara, AsiaNet /-- COVID-19 has become a global pandemic. China’s successful control of the pandemic has set a good example for other countries. Many have followed China to take effective measures like enforcing lockdowns and wearing masks have all been proved to be...

  Medicom Announces UK Mask Manufacturing Facility in Alliance w... - 26 June 2020 06:00

MONTREAL, June 26, 2020 /PRNewswire-AsiaNet/ -- The Medicom Group, ("Medicom"), one of the world's leading manufacturers of medical and respiratory masks, has announced the further expansion of its global footprint with the plan to open a new mask manufacturing facility in the United Kingdom th...

  OneDraw(TM) Blood Collection Device Receives the Red Dot Award... - 25 June 2020 23:00

MENLO PARK, California, June 25, 2020 /PRNewswire-AsiaNet/ -- Drawbridge Health today announced that the OneDraw(TM) Blood Collection Device, the enabling technology for the FDA cleared OneDraw(TM) A1C Test System, has won the prestigious Red Dot Award: Product Design 2020( https://c212.net/c/link/?t=0&l=en&...